Equities

Inspire Medical Systems Inc

Inspire Medical Systems Inc

Actions
  • Price (EUR)181.50
  • Today's Change3.90 / 2.20%
  • Shares traded4.00
  • 1 Year change+37.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 15:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments460451214
Total Receivables, Net906134
Total Inventory341217
Prepaid expenses9.605.512.66
Other current assets, total------
Total current assets594530269
Property, plant & equipment, net632416
Goodwill, net------
Intangibles, net------
Long term investments9.1409.94
Note receivable - long term------
Other long term assets11110.20
Total assets677565295
LIABILITIES
Accounts payable392712
Accrued expenses393420
Notes payable/short-term debt000
Current portion long-term debt/capital leases--09.19
Other current liabilities, total------
Total current liabilities786141
Total long term debt0016
Total debt0025
Deferred income tax------
Minority interest------
Other liabilities, total267.688.93
Total liabilities1046966
SHAREHOLDERS EQUITY
Common stock0.030.030.03
Additional paid-in capital917820508
Retained earnings (accumulated deficit)(345)(324)(279)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.80(0.09)(0.06)
Total equity573496229
Total liabilities & shareholders' equity677565295
Total common shares outstanding302927
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.